225 related articles for article (PubMed ID: 26879574)
1. Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma.
Chen SR; Qiu HC; Hu Y; Wang Y; Wang YT
Phytother Res; 2016 Jun; 30(6):863-77. PubMed ID: 26879574
[TBL] [Abstract][Full Text] [Related]
2. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
[TBL] [Abstract][Full Text] [Related]
3. The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
Dahmani R; Just PA; Perret C
Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):709-13. PubMed ID: 21778132
[TBL] [Abstract][Full Text] [Related]
4. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.
Vilchez V; Turcios L; Marti F; Gedaly R
World J Gastroenterol; 2016 Jan; 22(2):823-32. PubMed ID: 26811628
[TBL] [Abstract][Full Text] [Related]
5. Preventive and therapeutic role of traditional Chinese herbal medicine in hepatocellular carcinoma.
Ting CT; Li WC; Chen CY; Tsai TH
J Chin Med Assoc; 2015 Mar; 78(3):139-44. PubMed ID: 25447209
[TBL] [Abstract][Full Text] [Related]
6. Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.
Zamani P; Matbou Riahi M; Momtazi-Borojeni AA; Jamialahmadi K
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1301-1313. PubMed ID: 29025272
[TBL] [Abstract][Full Text] [Related]
7. Novel molecular targets for diagnosis and treatment of hepatocellular carcinoma.
Ma L; Ji L; Yu Y; Wang J
Discov Med; 2015 Jan; 19(102):7-14. PubMed ID: 25636956
[TBL] [Abstract][Full Text] [Related]
8. Ethyl acetate extract from Jiedu Xiaozheng Yin inhibits the proliferation of human hepatocellular carcinoma cells by suppressing polycomb gene product Bmi1 and Wnt/β-catenin signaling.
Chen XZ; Cao ZY; Li JN; Hu HX; Zhang YQ; Huang YM; Liu ZZ; Hu D; Liao LM; Du J
Oncol Rep; 2014 Dec; 32(6):2710-8. PubMed ID: 25333742
[TBL] [Abstract][Full Text] [Related]
9. Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma.
Cervello M; Augello G; Cusimano A; Emma MR; Balasus D; Azzolina A; McCubrey JA; Montalto G
Adv Biol Regul; 2017 Aug; 65():59-76. PubMed ID: 28619606
[TBL] [Abstract][Full Text] [Related]
10. An Overview of Natural Plant Products in the Treatment of Hepatocellular Carcinoma.
Rawat D; Shrivastava S; Naik RA; Chhonker SK; Mehrotra A; Koiri RK
Anticancer Agents Med Chem; 2018; 18(13):1838-1859. PubMed ID: 29866017
[TBL] [Abstract][Full Text] [Related]
11. Bruceine D inhibits hepatocellular carcinoma growth by targeting β-catenin/jagged1 pathways.
Cheng Z; Yuan X; Qu Y; Li X; Wu G; Li C; Zu X; Yang N; Ke X; Zhou J; Xie N; Xu X; Liu S; Shen Y; Li H; Zhang W
Cancer Lett; 2017 Sep; 403():195-205. PubMed ID: 28645563
[TBL] [Abstract][Full Text] [Related]
12. Chinese medicines for prevention and treatment of human hepatocellular carcinoma: current progress on pharmacological actions and mechanisms.
Wang X; Wang N; Cheung F; Lao L; Li C; Feng Y
J Integr Med; 2015 May; 13(3):142-64. PubMed ID: 26006028
[TBL] [Abstract][Full Text] [Related]
13. Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Shu X; McCulloch M; Xiao H; Broffman M; Gao J
Integr Cancer Ther; 2005 Sep; 4(3):219-29. PubMed ID: 16113029
[TBL] [Abstract][Full Text] [Related]
14. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Ma L; Wang X; Jia T; Wei W; Chua MS; So S
Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
Liu M; Bamodu OA; Kuo KT; Lee WH; Lin YK; Wu ATH; M H; Tzeng YM; Yeh CT; Tsai JT
Am J Chin Med; 2018; 46(4):891-910. PubMed ID: 29792038
[TBL] [Abstract][Full Text] [Related]
16. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
Pez F; Lopez A; Kim M; Wands JR; Caron de Fromentel C; Merle P
J Hepatol; 2013 Nov; 59(5):1107-17. PubMed ID: 23835194
[TBL] [Abstract][Full Text] [Related]
17. V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling - a new option for HCC therapy.
Bartel K; Winzi M; Ulrich M; Koeberle A; Menche D; Werz O; Müller R; Guck J; Vollmar AM; von Schwarzenberg K
Oncotarget; 2017 Feb; 8(6):9476-9487. PubMed ID: 28036299
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations in hepatocellular carcinoma: An update.
Niu ZS; Niu XJ; Wang WH
World J Gastroenterol; 2016 Nov; 22(41):9069-9095. PubMed ID: 27895396
[TBL] [Abstract][Full Text] [Related]
19. An Integrative Analysis Reveals the Potential Mechanism between Herbal Medicine Yinchen and Immunoregulation in Hepatocellular Carcinoma.
Mo Z; Cao Z; Yu L; Wang Y; Li P; Lin Y; Zhang S
Biomed Res Int; 2020; 2020():8886914. PubMed ID: 33457419
[No Abstract] [Full Text] [Related]
20. Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.
Gish RG; Finn RS; Marrero JA
Clin Adv Hematol Oncol; 2013 Apr; 11 Suppl 5():1-22; quiz 2 p following p22. PubMed ID: 23881427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
